These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 34167837)
1. Preclinical evaluation of recombinant HFMD vaccine based on enterovirus 71 (EV71) virus-like particles (VLP): Immunogenicity, efficacy and toxicology. Wang Z; Zhou C; Gao F; Zhu Q; Jiang Y; Ma X; Hu Y; Shi L; Wang X; Zhang C; Liu B; Shen L; Mao Q; Liu G Vaccine; 2021 Jul; 39(31):4296-4305. PubMed ID: 34167837 [TBL] [Abstract][Full Text] [Related]
2. Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in Yang Z; Gao F; Wang X; Shi L; Zhou Z; Jiang Y; Ma X; Zhang C; Zhou C; Zeng X; Liu G; Fan J; Mao Q; Shi L Hum Vaccin Immunother; 2020 Jul; 16(7):1602-1610. PubMed ID: 31403352 [TBL] [Abstract][Full Text] [Related]
3. High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice. Zhang C; Ku Z; Liu Q; Wang X; Chen T; Ye X; Li D; Jin X; Huang Z Vaccine; 2015 May; 33(20):2335-41. PubMed ID: 25820068 [TBL] [Abstract][Full Text] [Related]
4. A virus-like particle-based tetravalent vaccine for hand, foot, and mouth disease elicits broad and balanced protective immunity. Zhang W; Dai W; Zhang C; Zhou Y; Xiong P; Wang S; Ye X; Liu Q; Zhou D; Huang Z Emerg Microbes Infect; 2018 May; 7(1):94. PubMed ID: 29777102 [TBL] [Abstract][Full Text] [Related]
5. Protective effect of enterovirus‑71 (EV71) virus‑like particle vaccine against lethal EV71 infection in a neonatal mouse model. Cao L; Mao F; Pang Z; Yi Y; Qiu F; Tian R; Meng Q; Jia Z; Bi S Mol Med Rep; 2015 Aug; 12(2):2473-80. PubMed ID: 25936344 [TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice. Huo C; Yang J; Lei L; Qiao L; Xin J; Pan Z Vaccine; 2017 Dec; 35(52):7322-7330. PubMed ID: 29129453 [TBL] [Abstract][Full Text] [Related]
7. Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease. Tsou YL; Lin YW; Shao HY; Yu SL; Wu SR; Lin HY; Liu CC; Huang C; Chong P; Chow YH PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003692. PubMed ID: 25855976 [TBL] [Abstract][Full Text] [Related]
8. Crystal Structures of Yeast-Produced Enterovirus 71 and Enterovirus 71/Coxsackievirus A16 Chimeric Virus-Like Particles Provide the Structural Basis for Novel Vaccine Design against Hand-Foot-and-Mouth Disease. Lyu K; He YL; Li HY; Chen R J Virol; 2015 Jun; 89(12):6196-208. PubMed ID: 25833050 [TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and protective efficacy of an EV71 virus-like particle vaccine against lethal challenge in newborn mice. Sun S; Gao F; Mao Q; Shao J; Jiang L; Liu D; Wang Y; Yao X; Wu X; Sun B; Zhao D; Ma Y; Lu J; Kong W; Jiang C; Liang Z Hum Vaccin Immunother; 2015; 11(10):2406-13. PubMed ID: 26036916 [TBL] [Abstract][Full Text] [Related]
10. Chimeric enterovirus 71 virus-like particle displaying conserved coxsackievirus A16 epitopes elicits potent immune responses and protects mice against lethal EV71 and CA16 infection. Luo J; Huo C; Qin H; Hu J; Lei L; Pan Z Vaccine; 2021 Jul; 39(30):4135-4143. PubMed ID: 34116877 [TBL] [Abstract][Full Text] [Related]
11. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice. Ku Z; Liu Q; Ye X; Cai Y; Wang X; Shi J; Li D; Jin X; An W; Huang Z Vaccine; 2014 Jul; 32(34):4296-303. PubMed ID: 24950363 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of monovalent and bivalent vaccines against lethal Enterovirus 71 and Coxsackievirus A16 infection in newborn mice. Sun S; Jiang L; Liang Z; Mao Q; Su W; Zhang H; Li X; Jin J; Xu L; Zhao D; Fan P; An D; Yang P; Lu J; Lv X; Sun B; Xu F; Kong W; Jiang C Hum Vaccin Immunother; 2014; 10(10):2885-95. PubMed ID: 25483672 [TBL] [Abstract][Full Text] [Related]
13. A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice. Yang L; Liu Y; Li S; Zhao H; Lin Q; Yu H; Huang X; Zheng Q; Cheng T; Xia N Vaccine; 2016 Nov; 34(48):5938-5945. PubMed ID: 27771182 [TBL] [Abstract][Full Text] [Related]
14. Production of EV71 vaccine candidates. Chong P; Hsieh SY; Liu CC; Chou AH; Chang JY; Wu SC; Liu SJ; Chow YH; Su IJ; Klein M Hum Vaccin Immunother; 2012 Dec; 8(12):1775-83. PubMed ID: 22992566 [TBL] [Abstract][Full Text] [Related]
15. Induction of a high-titered antibody response using HIV gag-EV71 VP1-based virus-like particles with the capacity to protect newborn mice challenged with a lethal dose of enterovirus 71. Wang X; Dong K; Long M; Lin F; Gao Z; Wang L; Zhang Z; Chen X; Dai Y; Wang H; Zhang H Arch Virol; 2018 Jul; 163(7):1851-1861. PubMed ID: 29582164 [TBL] [Abstract][Full Text] [Related]
16. A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses. Cai Y; Ku Z; Liu Q; Leng Q; Huang Z Vaccine; 2014 May; 32(21):2406-12. PubMed ID: 24657161 [TBL] [Abstract][Full Text] [Related]
17. Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice. Li HY; Han JF; Qin CF; Chen R Vaccine; 2013 Jul; 31(32):3281-7. PubMed ID: 23726823 [TBL] [Abstract][Full Text] [Related]
18. Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles. Lin YL; Yu CI; Hu YC; Tsai TJ; Kuo YC; Chi WK; Lin AN; Chiang BL Vaccine; 2012 Feb; 30(7):1305-12. PubMed ID: 22214888 [TBL] [Abstract][Full Text] [Related]
19. Characterization of the enterovirus 71 P1 polyprotein expressed in Pichia pastor as a candidate vaccine. Han X; Ying XL; Zhou SL; Han T; Huang H; Jin Q; Yang F; Sun QY; Sun XX Hum Vaccin Immunother; 2014; 10(8):2220-6. PubMed ID: 25424925 [TBL] [Abstract][Full Text] [Related]
20. EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge. Wang X; Xiao X; Zhao M; Liu W; Pang L; Sun X; Cen S; Yang BB; Huang Y; Sheng W; Zeng Y BMC Res Notes; 2016 Jan; 9():42. PubMed ID: 26809443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]